Monobind

Monobind — FDA 510(k) Submissions

Monobind has submitted 21 FDA 510(k) premarket notifications since 1977, of which 21 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Total Triiodothyronine, Radioimmunoassay, Follicle-stimulating Hormone, Radioimmunoassay, Prolactin (lactogen), Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine, Radioimmunoassay, Total Thyroxine . Use the specialty filter in the sidebar to narrow results.